IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes
Description
CONCLUSIONS: The distinct progression of IL-6 levels in the course of the disease, especially on days 10-16, was a good marker of progression to critical status and mortality and could guide the start of IL-6 blockade. cfDNA was an accurate marker of